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Cardiac troponin I contains IWO adjacent serincs in sequence after three argininc residues thus making up a minimally duplicated recognition motif 
for CAMP-dependent protein kinasc. In a synthetic pcptidc. PVRRRSSANY. the two serine residues arc phosphorylated scquexially with the 
intermediate formation op monophosphorylalcd species according to the followinp reaction sequence: 
Peptide 2 Peptide-P 2 Peptide-P,. The calculated rate constants are: /r: = 0.435,min-’ and k? = 0.034.min-‘. Sequence analyses 
of the monophosphopeptidc and its cryptic fragments how that the predominant monophosphoform carriLz phosphate ai the second serine, 
Cardiac troponin I; Troponin I peptidc: CAMP-depndcnt protein kinase; Phosphoscrinc; Ordered phosphorylation; Trypiic cleavapc 
1. INTRODUCTION 2. EXPERIMENTAL 
Phosphorylation of cardiac troponin I occurs upon 
p-adrencrgic stimulation [l]. In rat heart increase in 
force development correlates with incorporation of ap- 
proximately 1 mol of phosphate per mol of troponin I 
[l]. The N-terminal region of cardiac troponin I, how- 
ever, contains two serine residues both of which can be 
phosphorylated [2]. These two adjacent serine residues 
are preceded by three arginine residues in four species, 
bovine, rabbit, rat and man [3-61; a downstream alanine 
is absent in human cardiac troponin I [4]. From bovine, 
rabbit and human heart, troponin I has been isolated in 
non-, mono- and bisphosphorylated forms [2.4]. In the 
test tube, CAMP-, cGMP-dependent protein kinase, as 
well as protein kinase C, phosphorylate both serine res- 
idues without an apparent specificity towards one or 
other of these two hydroxy amino acids [2]. The product 
of troponin I phosphorylation in vitro is the 
bisphosphorylated form. To date it is not known how 
monophosphorylated cardiac troponin I is generated. 
In this report we have employed the synthetic peptide, 
PVRRRSSANY, derived from the phosphorylation do- 
main of cardiac troponin 1. It will be shown that CAMP- 
dependent protein kinase predominantly phospho- 
rylates the second serine residue before touching the 
first one. 
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A solid-phase Cumbridgc Research Biochemical Pepsynthesizer II 
was employed comaining I g of r-butyl-Tyr-ppsyn KA (Milli Gcn, 
Eschborn, Germany) in lhe column. For coupling, a 4-fold excess of 
Ihe appropriate Fmoc (9.Ruorenylmethoxycarbonyl)_protectedamino 
acid (pentafluorophcnylencr, in case ofserine oxo-benzo-triazolester) 
dissolved in dimethylformamide was applied. The side chain of ar@ninc 
was protected by a 4-melhoxy-2,3.6-trimethylphenylsulfonyl group. 
Serinc carried a r-buiyl group. For dc-protection of the N- terminal 
Fmoc group, ~hc resin was washed with 20% pipcridine in dimnhylfor- 
mamide. Following synthesis the pplide resin was washed with di- 
nxthylformamide. tr-amylalcohol and dicthylcther. After drying and 
10 min prc-incubation with the scavengers. thioanisol and ethanes 
dithiol (2:1, by volume), de-prelection and cleavage of the peptidc 
from the resin were carried out with trifiuoroacetic acid and WIuoro- 
methancsulfonic a id (1O:l. by volume). The pepiide was precipitaled 
in pm-cooled r-butyl-methylether. After ccntrifugaation, the precipitate 
was dried in vacua. The solubilized pcplidc was purified preparadvely 
by HPLC on rcvcrsc-phase Cl% material. A linear gradient was used 
consisting of 0.09% trifluoroacetic acid (solvent A), and 0.08% lri- 
fluoroacetic acid and 84% acetonitrite (solvem B). Purity and quantity 
of the peptide were determined by amino acid and squence analysis. 
Troponin was isolated from bovine heart according 10 the method 
of [7] modified by [8]. Separation of the troponin I subunit was c;lrricd 
out as described previously [9]. The pbosphale contcnl of hololro- 
ponin and troponin I was dctcrmined by the mclhod of]lO]. 
Phosphorylation ofiroponin 1. the troponin complex or the peplidc 
(12-l 5 PM) by CAMP-dependent protein kinasc (IO-250 U/ml, cata- 
lylic subunit. Sigma) was carried out al 30°C in 50 mM mor- 
pbolinopropane sulfonic acid, pH 7.0. 10 mM M&Y.. lo0 PM 
[y-“:P]ATP, I mM DTE and, in the case of the holocomplex. addition- 
ally 100 mM KCI. Incorporation or[‘zP]phosphau was determined by 
the method of [ I I]. 
The synlbctic peplide und its phosphorylated forms were digested 
with lrypsin as described [9]. The generated fragments were separated 
on a Cl8 218 TP 5415 Vydnc reverse-phase HPLC column (4.6~150 
mm j. A linear gradient from 5 lo 36% solvent B in solvent A over 25 
min was employed al a flow r,le of I ml/min. The absorbance was 
recorded at 214 nm. 
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Prior to amino acid analysis phosphopeptides wcrc prepurcd for 
S-ethylcystein~ analysis as described previously [9,12]. Amino acid 
unalysis was ~rforn~cd as described [13], Edm~n degradation of the 
synth& peptide and its phosphory~ated forms was carried out as 
described [2], To loculize the [““PIphosphate in the amino acid SC- 
quencc of a phosphopeptide, the method ol’ [14] was employed with 
a modification as described by [2]. 
3. RESULTS 
Phosphorylation of a synthetic peptide, PVRRRSa 
SANY, corresponding to the phosphorylation domain 
of bovine, rabbit and rat cardiac troponin I by the 
catalytic subunit of CAMP-dependent protein kinase is 
compared to that of isolated troponill I and holotro- 
ponin. 1,7 mol of phosphate/m01 of synthetic peptide 
are incorporated within 30 min. but further phosphoryl- 
ation is very slow (Fig. I), A somewhat slower time- 
course is observed when isolated cardiac troponin I is 
employed; in contrast, phosphorylation of troponin I 
present in the holocomplex occurs more rapidly. 
Reverse-phase HPLC allows the separation of the 
mixture of products generated uring phosphorylation 
of the peptide for 3 or 90 min (Fig. 2). The substrate, 
the non-phosphorylated peptide (I), elutes at 9.5% sol- 
vent B. During phosphorylation, the amount of non- 
phosphor~lated peptide decreases and finally disap- 
pears completely. Two new peptides (II and III) appear, 
eluting successively at 1 and 2% lower concentrations 
of solvent B. The amino acid composition of peptide I
and that of the two phosphopeptides II and III is shown 
Time I mid 
Fig. I. Phosphorylation of the synthetic peptidc PVRRRSSANY, the 
cardiac holotroponin complex and the cardiuc troponin I subunil by 
CAMP-dependent protein kinasc. Phosphorylation of each substrate 
(15 PM) by the catalyric subunit of CAMP-dcpcndent proicin kinasc 
(250 U/ml) was carried out as described in section 2, The elldo~enous 
phosphate content of the holocomp!cx f=> bcforc incubation with 
protein kinase was 0.8 moi of phosphatelmoi f troponin I. The cm- 
ployed troponin I subunit (A) contained 0.5 lnol of phosphatc/mol f
protein. The synthetic decapeptidc (0) was fret of cndogcnous 
phosphate, slow liberalion. 
I l;i lb II Ila Ilb III Illa 
Asx 0.8 I.0 1.0 0.9 0,9 1.0 0.8 0.8 
Ser 1.8 1.8 I .9 0.9 0.9 0.9 - - 
Ser(P) - - - 0.9 0.8 0.8 1.7 I.5 
Arg 27 - 1.1 2.6 1+1 21 2.7 I.9 
Alit I,1 0,9 1,o 1.0 0,Q 0.9 1,o 0,9 
Pro I.3 - - I.1 - - I.2 - 
Tyr I.0 I.0 1,o I.0 I,0 1.0 I.0 1.0 
Val I.1 - - 0.9 - - I.0 - 
Amino acid analyses before and after tryptit di&estion follo~~in~ con- 
version of p~to~phc~erine to ~-et~t~flcysleine wer  carried out in dupll- 
cite as described in section 2. Pcptide la, lb, Ha, Ilb and IIla were the 
serinc-contilining fragmcnls after tryptic digestion of the correspond. 
ing pcptide 1. II or 111. Values were not corrected for destruction and 
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in Table 1. As expected, peptide I, the substrate, con- 
tains no phosphoserine, whereas the amount of 
pl~osphoserille in peptide II extrapolates to 1 mol of 
phosphoserine/mol of peptide and that of peptide III to 
2 mol of phosphoserine/mol f peptide (Table I), 
Employing this separation technique the time-course 
of appearance and disappearance of all species formed 
during phosphorylation can be followed. The amount 
of each species was determined either by measuril~~ the 
t’?P]phosphate content or by analyzing the amino acid 
composition. The non-phosphorylated substrate disap. 
pears almost completely within 10 min; the amount of 
monophosphorylated peptide rises quickly and disap 
pears more slowly (Fig. 3). The lnonophosphorylated 
form reaches maximally ea. 80% of the total amount OF 
peptide mployed. The bisphosphopeptide appears after 
a short lag phase; its increase correlates with the de- 
crease of the monophosphorylated form. This observa- 
tion suggests an ordered phosphorylatioI1 occurring 
first at one serine and CoIlsecutively at the second serine 
residue, Therefore, the following reaction mechanism 
can be postulated: 
ATP ADP ATP ADP 
L k, / \&%J Peptidc + Peptide-P --_* Peptide-P, 
Peptide-P and Peptide-P, represent the mono- and 
bisphosphorylated peptides, respectively. Assuming 
that ATP remains constant during phosphorylation, 
these reactions can be described by the following set of 
differential rate equations: 
d[Peptide-P]/dr = [Peptidelak, - [Peptide-P]ak, 
d[Peptide-PJ/dt = [Peptide-P].k? 
d[Peptide]/dt = -d[Peptide-PI/d t - d [Peptide-P&d! 
Amino acid analysis ol’differem phosphorylatcd pcptides bcrore and 
after tryptic digestion 
Anlii~o 
acid 
Peptide 
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Fig. 2. HPLC ahalyscs of the synthetic peptidc phosphorylatad by 
CAMP-dcpcndcnt protein kinasc. The pcptide PVRRRSSANY (12 
yM) was phosphorylated with CAMP-dcpcndcnt protein kinusc (100 
U/ml) as described above (Fig. I ). After 0 min (A), 3 min ! R) ;md 90 
min (C) incubation, aliquots containing I ,6 nmol ol’ pcplidc wcrc 
separated on a reverse-phase HPLC column us described in section 2. 
The system was solved by using the numerical soft- 
ware MATLAB. The optimal adaptation to the expcri- 
mental data was achieved employing the rate constants 
k, = 0.435 min-’ and kl = 0.034 min-’ (Fig. 3). 
In this reaction sequence potentially two mono- 
phosphorylated species can be formed, namely the one 
phosphorylated on the first or on the second serine 
residue. Therefore, the monophosphorylated peptide is 
isolated by HPLC as shown in Fig. 2. During Edmnn 
degradation phosphoserine forms dehydroalanine and 
inorganic phosphate thus allowing the determination of 
the step at which [‘*P]phosphate is liberated. The au- 
toradiogram following high-voltage iontophoresis 
shows that a low amount of inorganic phosphate is 
liberated from the first serine (Fig. 4, peptide II). At the 
0 20 LO 60 80 
Time (mini 
Fig. 3. PhosphopcpGde formation during phosphorylation of the syn- 
thetic pptidc PVRRRSSANY, Phosphorylation conditions and isola- 
tion of the phosphopeptides arc described above (Fig. 2). The amount 
or each pptidc, the non-phosphorylaled substrate (I), the mono- 
phosphorylatcd (a), and the bisphosphorylatcd form (A). is dcter- 
mined by [“!P]phosphate content or by amino acid analysis as de- 
scribed in slrtion 2. The curves calculated with th!: rate constants, k, 
nnd kz (given in the text). reprcscnt the optimal adaptation to the 
expcrimcntal data employing the software MATLAB. 
position of the second serine more than twice the 
amount of p”P]phosphate is found, This indicates that 
a minor amount of phosphate is incorporated into the 
first serine. and the major amount into the second 
se;:ne. Apparently, these two monophosphorylated spe- 
cies are not separated by HPLC, which prevents an easy 
quantification of each mor:ophospho form. 
As an alternate approach, these pptides were di- 
gested with trypsin. The bisphosphorylated peptide is 
cleaved exclusively after the first arginine yielding the 
fragment Illa, RRS(P)S(P)ANY (Fig. SC and D. Table 
I). In contrast, the non-phosphorylated peptide yields 
SSANY as the major product fragment la, resulting 
from cleavage after the third arginine. Only a minor 
part of this peptide is cleaved between the second and 
the third arginine residue, which produces fragment lb 
(Fig. 5A and D, Table I). Digestion of the mono- 
phosphopeplide II. which represents a mixture of both 
possible monophospho species, results in two major 
fragments Ila and Ilb; IIa contains one arginine residue 
and IJb contains two (Fig. 5B and D, Table I). Peptide 
Ha is homogeneous: it does not liberate inorganic phos- 
phate during Edman degradation of the first serine res- 
idue; radioactivity is liberated, however, during the sub- 
sequent cycle, i.e. upon degradation of the second serine 
residue (Fig. 4). During Edman degradation Peak Ilb 
behaves like the non-digested monophosphorylated 
peptide II; r?P]phosphate is liberated mainly upon deg- 
radation of the second serine residue. Thus, trypsin 
cleaves the monophosphopeptide- containing 
phosphoserine in the second position after the first or 
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Fig. 4. Localization of [“P]phosphoserine in the amino acid sequence 
of the synthetic monophosphopcptide and its tryptic fragments. The 
isolated [‘:P]monophosphopeptide II (see Fig. 2) and the tryptic frag- 
tncms 11s and IIb (see Fig. 5) are subjected to Edman degradation. 
Sequence ana!ysis is interrupted after the first and the second serine, 
rcspcctivcly. Liberated [“‘PIphosphate is identlticd as described by [2]. 
The autoradiogram shows the position ofthc llbcralcd [“Vlphosphate 
and the radioactively labclled residual peptidc. Lam I, radioactivity 
distribution after interruption at the first serine, lane 2. at the second 
serine residue, and lane 3 is the [JzP]phosphatc standard. 
the second arginine residue (see Fig. SD), whereas it 
cleaves the monophosphopeptide-carrying phosphos- 
erine at the first position exclusively after the first argin- 
inc. Again, the two resulting fragments composed of 
two arginine residues and one phosphoserine. iriespec- 
tive of the position (peak IIb), are not separated by 
reverse-phase HPLC chromatography. 
4. DISCUSSION 
The minimal recognition motif for CAMP-dependent 
protein kinase is generally accepted to be RRXS [15]. 
Cardiac troponin I contains this motif in a duplicated 
form represented by the sequence RRRSS. The three 
basic amino acids are arranged in such a way that the 
first, as well as the second, serine residue fulfills the 
requirement of the minimal recognition motif (see 
above). As demonstrated here, both serine residues are 
phosphorylated by CAMP-dependent protein kinase 
when a synth& peplide comprising tile duplicated 
minimal recognition motif is employed. In comparison 
with other substrates this duplication does not drasti- 
cally change the properties as substrate: the KM value 
of 4 PM determined by measuring the initial pP]phos- 
phate incorporation rate (not shown) is similar to that 
of 8 FM reported for another synthetic peptidc. kemp- 
tide [16]. 
There are principally two possibilities for a dupli- 
cated substrate motif to be positioned in the catalytic 
center of the protein kinase: either the first or the second 
serine is phosphorylated (for description of the catalytic 
ten ter compare [ 17,181 j. The results hown here suggest 
that the preferred position is the one in which the second 
serine can accept he phosphate group. When analyzing 
the mixture of monophosphorylated peptides it can 
clearly be seen that the major part of the incorporated 
[“?P]phosphate is found at the second serine and only a 
minor part at the first serine (see Fig. 4). The cleavage 
pattern of these monophosphopeptides with trypsin is 
in agreement with this conclusion (see Fig. 5). This pro- 
tease is unable to cleave a peptide bond after arginine 
or lysine if a phosphoserine is located two positions 
downstream (compare Fig. 5, peptides IIa, Ilb and 
IIIa). This pattern was also observed by Parker et al. 
[19] and Picton et al. [20]. The situation is somewhat 
more complicated here due to the presence of multiple 
arginine residues; they lead to additional cleavage prod- 
ucts by clipping further upstream from phosphoserine. 
Nevertheless this analysis also leads to the conclusion 
that the second serine is pf?zsi;horylated first. 
Meanwhile, accumulation of a monophosphoform 
during phosphorylalion of troponin I present in the 
holocomplex by CAMP-dependent protein kinase has 
been detected (D. Soprani, personal communication). 
This suggests that such an ordered sequeqtial phospho- 
rylation of troponin 1 also occurs in the native protein. 
The opposite behavior has been observed by phospho- 
rylating skeletal muscle troponin T with phosphorylase 
kinase [2l]. In analogy to cardiac troponin I two serine 
residues, !ocated in position 149/l 50 and 156/l 57, are 
phosphorylated: a monophosphoform has never been 
detected uring phosphorylation. In this instance, how- 
ever, a monophosphoform is formed upon de-phospho- 
rylation by a protein phosphatase. Thus, differential 
phosphorylation or de-phosphorylation can generate 
intermediate monophosphorylated species which may 
represent important differences in regulation by protein 
kinase or.protein phosphatase. 
As a consequence of sequential phosphorylation 01 
de-phosphurylation multiple forms are produced. The 
number of forms,S, increases according toJ= 2” where 
II is the number of phosphorylatable residues, in this 
case serine. In such a system each species may have a 
different function. Alternatively, only two functional 
states may exist which are represented by the fully de- 
phosphorylated and the fully phosphorylated proteins. 
Partially phosphory:ated forms then could bc intcrme- 
diates in this functional transition, exhibiting the same 
function to different degrees. Cardiac troponin I might 
be the optimal system to analyze such a situation since 
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Fig. 5. Separation oftryptic fruymenls obtained from non-, mono- and 
bisphosphorylalcd peptidcs and the resulting cleavage sites of trypsin. 
20 nmol or pepiidc I (A), 33 nmol orpsptide II (B) and 20 nmol of 
peptide 111 (C) were d&sled wilh trypsin ;1s described by [9]. The 
fragments wcrr separated on ;I rcvcrsc-phase HPLC column as dc- 
scribed under section 2. The cleavage siles ol’trypsin in the synthetic 
decapcptide und iu phosphoforms (D) arc shown (see Fig. 4. Tablc 
I), The major poshion at which the pcpiidc was clcavcd is marked by 
a thick arrow, and the minor clcavagc she by iI thin arrow. 
only four states have to be analyzed ue to the presence 
of two phosyhoserine residues. 
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